Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Pozzilli

Showing results (101-110 of 247) with videos related to

Pageof 25
Sort By:
Plos One|June 27, 2013
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosisNikolaos Petsas, Emanuele Tinelli, Delia Lenzi, et al.
Neurorehabilitation and Neural Repair|November 23, 2014
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple SclerosisNikolaos Petsas, Valentina Tomassini, Nicola Filippini, et al.
European Journal of Neurology|March 17, 2022
Relation of sensorimotor and cognitive cerebellum functional connectivity with brain structural damage in patients with multiple sclerosis and no disabilitySilvia Tommasin, Viktoriia Iakovleva, Maria Assunta Rocca, et al.
Lancet (London, England)|September 29, 2004
Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trialOtto R Hommes, Per S Sørensen, Franz Fazekas, et al.
Human Brain Mapping|November 3, 2006
Effect of corpus callosum damage on ipsilateral motor activation in patients with multiple sclerosis: a functional and anatomical studyDelia Lenzi, Antonella Conte, Caterina Mainero, et al.
Clinical Neuropharmacology|June 4, 2008
Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa studyAlessandra Lugaresi, Valentina Durastanti, Claudio Gasperini, et al.
Neurology|July 24, 2019
Effect of dalfampridine on information processing speed impairment in multiple sclerosisLaura De Giglio, Francesca De Luca, Flavia Gurreri, et al.
Neurology|May 11, 2016
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosisAndrea Truini, Luca Prosperini, Valentina Calistri, et al.
Journal of Neurology|May 24, 2022
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinionMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Journal of Neurology|August 10, 2025
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensusMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Pageof 25

Showing results (101-110 of 247) with videos related to

Sort By:
Pageof 25
Plos One|June 27, 2013
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosisNikolaos Petsas, Emanuele Tinelli, Delia Lenzi, et al.
Neurorehabilitation and Neural Repair|November 23, 2014
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple SclerosisNikolaos Petsas, Valentina Tomassini, Nicola Filippini, et al.
European Journal of Neurology|March 17, 2022
Relation of sensorimotor and cognitive cerebellum functional connectivity with brain structural damage in patients with multiple sclerosis and no disabilitySilvia Tommasin, Viktoriia Iakovleva, Maria Assunta Rocca, et al.
Lancet (London, England)|September 29, 2004
Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trialOtto R Hommes, Per S Sørensen, Franz Fazekas, et al.
Human Brain Mapping|November 3, 2006
Effect of corpus callosum damage on ipsilateral motor activation in patients with multiple sclerosis: a functional and anatomical studyDelia Lenzi, Antonella Conte, Caterina Mainero, et al.
Clinical Neuropharmacology|June 4, 2008
Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa studyAlessandra Lugaresi, Valentina Durastanti, Claudio Gasperini, et al.
Neurology|July 24, 2019
Effect of dalfampridine on information processing speed impairment in multiple sclerosisLaura De Giglio, Francesca De Luca, Flavia Gurreri, et al.
Neurology|May 11, 2016
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosisAndrea Truini, Luca Prosperini, Valentina Calistri, et al.
Journal of Neurology|May 24, 2022
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinionMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Journal of Neurology|August 10, 2025
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensusMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Pageof 25